Exodus Point Capital Management, LP Opti Nose, Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$1.63 - $2.02 $21,957 - $27,211	13,471 New	13,471 $26,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.16 $107,959 - $145,170	-45,940 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.91 - $3.83 $133,685 - $175,950	45,940 New	45,940 $143,000
Q1 2021 May 17, 2021	SELL	$3.47 - $4.75 $196,048 - $268,365	-56,498 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.2 - $4.98 $180,793 - $281,360	56,498 New	56,498 $234,000
Q4 2019 Feb 14, 2020	SELL	$6.27 - $11.41 $68,970 - $125,510	-11,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.75 - $8.38 $52,250 - $92,180	11,000 New	11,000 $77,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $31.6M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.